Tilray, Inc. Series 2 ist eine Aktie aus dem Premium-Bereich von aktien.guide. Bitte anmelden, um einen Alarm für Tilray, Inc. Series 2 zu aktivieren.
Kostenlos registrieren
Bitte registriere Dich kostenlos, um Tilray, Inc. Series 2 zu Deinem Portfolio hinzuzufügen.
Tilray, Inc. Series 2 Aktie News
12,34 $
4,19 %
gestern
Nasdaq,
18. Dezember, 22:18 Uhr
Was hinter der Kursbewegung steckt Beta
aktien.guide Unlimited – alle Details der KI-Analysen
Mit Unlimited erhältst du die vollständige KI-Funktionalität für Tilray, Inc. Series 2. 👉 Detailliertere Insights 👉 Exklusive Einblicke in Chancen & Risiken 👉 Klare Antworten auf deine Fragen
U.S. President Donald Trump's move to relax marijuana regulations could ease some burden for cannabis companies, but will likely keep doors to access capital from big banks closed, experts said.
Expand NASDAQ: TLRY Tilray Brands Today's Change (-4.04%) $-0.52 Current Price $12.36 Key Data Points Market Cap $1.5B Day's Range $12.10 - $15.68 52wk Range $3.51 - $23.20 Volume 1.5M Avg Vol 10M Gross Margin 20.17% Tilray Brands (TLRY 4.04%), a global medical cannabis producer, closed Thursday at $12.34, down 4.2%. Tilray Brands IPO'd in 2018 and has fallen 94% since going public.
President Donald Trump on Thursday signed an executive order directing the federal government to move marijuana from Schedule I to Schedule III, potentially easing regulatory and financial constraints for cannabis companies while keeping recreational use illegal under federal law. The order instructs the attorney general to expedite the ongoing process of rescheduling marijuana, which is curren...
It has officially happened, Donald J Trump has signed the executive order to reschedule cannabis. Now, cannabis has been taken from a Class 1 to a Class 3 substance under the Controlled Substances. At this time, there is more to come in terms of what will take place specifically for legal operators and the cannabis industry overall. This push for reform has been ongoing for over a decade, and n...
President Donald Trump signed an executive order on Thursday directing federal agencies to reclassify marijuana from Schedule I to Schedule III. The move sent US cannabis stocks sharply higher on expectations of lighter regulation and expanded medical research.
Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for Healthcare Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for Healthcare
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.